Litcius/Paper detail

AD and non‐AD mediators of the pathway between the <i>APOE</i> genotype and cognition

Emma Nichols, Adam M. Brickman, Kaitlin B. Casaletto, Kristen Dams-O’Connor, Kristen M. George, Raj G. Kumar, Priya Palta, Jennifer S. Rabin, Claudia L. Satizábal, Julie A. Schneider, Judy Pa, Renaud La Joie

2022Alzheimer s & Dementia18 citationsDOIOpen Access PDF

Abstract

INTRODUCTION: The apolipoprotein E (APOE) genotype is a driver of cognitive decline and dementia. We used causal mediation methods to characterize pathways linking the APOE genotype to late-life cognition through Alzheimer's disease (AD) and non-AD neuropathologies. METHODS: We analyzed autopsy data from 1671 individuals from the Religious Orders Study, Memory and Aging Project, and Minority Aging Research Study (ROS/MAP/MARS) studies with cognitive assessment within 5 years of death and autopsy measures of AD (amyloid beta (Aβ), neurofibrillary tangles), vascular (athero/arteriolo-sclerosis, micro-infarcts/macro-infarcts), and non-AD neurodegenerative neuropathologies (TAR DNA protein 43 [TDP-43], Lewy bodies, amyloid angiopathy, hippocampal sclerosis). RESULTS: The detrimental effect of APOE ε4 on cognition was mediated by summary measures of AD and non-AD neurodegenerative neuropathologies but not vascular neuropathologies; effects were strongest in individuals with dementia. The protective effect of APOE ε2 was partly mediated by AD neuropathology and stronger in women than in men. DISCUSSION: The APOE genotype influences cognition and dementia through multiple neuropathological pathways, with implications for different therapeutic strategies targeting people at increased risk for dementia. HIGHLIGHTS: Both apolipoprotein E (APOE) ε2 and APOE ε4 effects on late-life cognition are mediated by AD neuropathology. The estimated mediated effects of most measures of AD neuropathology were similar. Non-Alzheimer's disease (AD) neurodegenerative pathologies mediate the effect of ε4 independently from AD. Non-AD vascular pathologies did not mediate the effect of the APOE genotype on cognition. The protective effect of APOE ε2 on cognition was stronger in women.

Topics & Concepts

NeuropathologyApolipoprotein EDementiaCerebral amyloid angiopathyPsychologyCognitionNeuroscienceCognitive declineDementia with Lewy bodiesDiseaseMedicinePathologyDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments
AD and non‐AD mediators of the pathway between the <i>APOE</i> genotype and cognition | Litcius